Retroviral protease inhibitors

Details Retroviral protease inhibitors Retroviral protease inhibitors

C - Chemistry, Metallurgy

07

D

C07D 215/54 (2006.01) A61K 31/17 (2006.01) A61K 31/195 (2006.01) A61K 31/197 (2006.01) A61K 31/27 (2006.01) A61K 31/33 (2006.01) A61K 31/47 (2006.01) A61K 31/4709 (2006.01) A61K 31/496 (2006.01) A61K 31/5377 (2006.01) C07C 213/02 (2006.01) C07C 271/20 (2006.01) C07C 271/22 (2006.01) C07C 275/14 (2006.01) C07C 275/18 (2006.01) C07C 275/24 (2006.01) C07C 275/28 (2006.01) C07C 311/47 (2006.01) C07C 317/44 (2006.01) C07C 317/50 (2006.01) C07C 323/60 (2006.01) C07C 335/12 (2006.01) C07D 213/40 (2006.01) C07D 213

Patent

CA 2096528

Compounds represented by formula (I) or a pharmaceutically acceptable salt, prodrug or ester thereof, wherein A represents radicals represented by formulae (A 1, A2, A3) (values for the variables given herein), are effective as retroviral protease inhibitors, and in particular as inhibitors of H1V protease.

Affiliated with

Also associated with

Rating

Retroviral protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Retroviral protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retroviral protease inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1373090